Category: Pharmaceuticals
North America Pharmaceuticals
-
Biologics Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global biologics contract manufacturing market is set for remarkable growth, with worldwide revenue anticipated to increase from USD 16.01 billion in 2024 to an impressive USD 36.3 billion by 2031. Projected to grow at ... Read More
-
Mental Health & Substance Abuse Services
... Acadia Healthcare, Hazelden Betty Ford Foundation, and Corewell Health (all based in the US), along with the Centre for Addiction and Mental Health (Canada) and the Crossroads Centre Antigua. COMPETITIVE LANDSCAPE Demand for mental health ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.) to reach $596,921,719,054 by 2031. Drug Stores ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
... that will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $77,985,958,669 by 2031. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.), including Average EBITDA, ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
... will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $312,882,043,584 by 2031. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210
... save countless hours of research. Key Findings: Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.) to reach $1,803,334,325,954 by 2031. Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.), including Average EBITDA, Operating Ratios and Sales per Employee. ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
... will save countless hours of research. Key Findings: Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.) to reach $387,074,915,562 by 2031. Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200
... will save countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $1,803,334,325,954 by 2031. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411
... forecasts that will save countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $20,249,315,761 by 2031. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.), ... Read More
-
Medical & Recreational Marijuana Stores in the US - Industry Market Research Report
... (by prescription only) and recreational marijuana, has expanded dramatically over the past five years. The legalization of marijuana for medical and/or recreational purposes and the growing acceptance of legal marijuana use provided operators and investors ... Read More
-
Pharmaceutical Contract Management Consulting in the US - Industry Market Research Report
... patents on blockbuster drugs, has stimulated the volume of research and development (R&D) work outsourced by generic pharmaceutical and biotechnology companies, promoting growth for consultants. The outbreak of COVID-19 led to growth for consultants as ... Read More
-
Institutional Pharmacies in the US - Industry Market Research Report
... These pharmacies are typically located within general and medical hospitals, nursing care facilities and assisted living communities, among others. Since industry demand is dictated by macro-level demographic, legislative and economic trends, the industry remains highly ... Read More
-
Pharmaceuticals & Pharmacy Supplies Wholesaling in Canada - Industry Market Research Report
... of external competition from manufacturers, which is endemic to most wholesale industries. Pharmaceutical wholesalers and self-distributing pharmacy chains, which are excluded from the industry, account for 95.0% of total pharmaceuticals distributed to pharmacies and to ... Read More
-
United States Health Insurance Market: Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.1% during 2025-2034. This report on United States health insurance market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Blood Transfusion Diagnostics
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$1.7 ... Read More
-
Produce Packaging Trays
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.0 ... Read More
-
Therapeutic Respiratory Devices
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$32.3 ... Read More
-
Office Administrative Services
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$62.1 Billion ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Counter Terror and Public Safety Technology
... the year 2023, is expected to reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Cyber Security Technology, one of the segments analyzed in the report, is expected ... Read More
-
Flea and Tick Products
... reach US$11.2 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach ... Read More
-
Vancomycin
... of 4.9% over the analysis period 2023-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis ... Read More
-
Insulin Pens
... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Nail Care
... at a CAGR of 2.5% over the analysis period 2023-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.3 Billion by the end of ... Read More
-
Veterinary Pain Management
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More
Research Assistance
